OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ
Kagan E. Karakus, Matthew P. Klein, Halis Kaan Aktürk, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 7, pp. 1647-1655
Open Access | Times Cited: 7
Kagan E. Karakus, Matthew P. Klein, Halis Kaan Aktürk, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 7, pp. 1647-1655
Open Access | Times Cited: 7
Showing 7 citing articles:
Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Mechanistic Pathways and Clinical Implications of GLP-1 Receptor Agonists in Type 1 Diabetes Management
Charlotte Delrue, Marijn M. Speeckaert
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9351-9351
Open Access | Times Cited: 3
Charlotte Delrue, Marijn M. Speeckaert
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9351-9351
Open Access | Times Cited: 3
Effect of Tirzepatide on Body Weight and Diabetes Control in Adults With Type 1 Diabetes and Overweight or Obesity
Rene Rivera Gutierrez, Elif Tama, Dima Bechenati, et al.
Mayo Clinic Proceedings (2024)
Closed Access | Times Cited: 2
Rene Rivera Gutierrez, Elif Tama, Dima Bechenati, et al.
Mayo Clinic Proceedings (2024)
Closed Access | Times Cited: 2
Managing obesity in adults with type 1 diabetes
Alejandro Campos, Rene Rivera Gutierrez, Rodolfo J. Galindo, et al.
Diabetes Research and Clinical Practice (2024) Vol. 220, pp. 111983-111983
Closed Access | Times Cited: 1
Alejandro Campos, Rene Rivera Gutierrez, Rodolfo J. Galindo, et al.
Diabetes Research and Clinical Practice (2024) Vol. 220, pp. 111983-111983
Closed Access | Times Cited: 1
Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes
Zeb Saeed, Halis Kaan Aktürk, Grazia Aleppo, et al.
Clinical Diabetes (2024) Vol. 43, Iss. 1, pp. 131-138
Closed Access
Zeb Saeed, Halis Kaan Aktürk, Grazia Aleppo, et al.
Clinical Diabetes (2024) Vol. 43, Iss. 1, pp. 131-138
Closed Access
GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study
Pernille Holmager, Merete B. Christensen, Kirsten Nørgaard, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access
Pernille Holmager, Merete B. Christensen, Kirsten Nørgaard, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access
Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies
Viral N. Shah, Rikke Mette Agesen, Lars Bardtrum, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access
Viral N. Shah, Rikke Mette Agesen, Lars Bardtrum, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access
